Patent 7863301 was granted and assigned to Wisconsin Alumni Research Foundation on January, 2011 by the United States Patent and Trademark Office.
The present invention relates to a recognition that an analog of αKG can increase glucose-induced insulin secretion in vitro and in vivo in animals, particularly in mammals, and more particularly in humans and in rodents. By employing the methods of the invention, insulin secretion can be increased.